Cargando…
Medicine-Based Evidence in Congenital Heart Disease: How Artificial Intelligence Can Guide Treatment Decisions for Individual Patients
Built on the foundation of the randomized controlled trial (RCT), Evidence Based Medicine (EBM) is at its best when optimizing outcomes for homogeneous cohorts of patients like those participating in an RCT. Its weakness is a failure to resolve a clinical quandary: patients appear for care individua...
Autores principales: | Van den Eynde, Jef, Manlhiot, Cedric, Van De Bruaene, Alexander, Diller, Gerhard-Paul, Frangi, Alejandro F., Budts, Werner, Kutty, Shelby |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674499/ https://www.ncbi.nlm.nih.gov/pubmed/34926630 http://dx.doi.org/10.3389/fcvm.2021.798215 |
Ejemplares similares
-
Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data
por: Van den Eynde, Jef, et al.
Publicado: (2023) -
Data Quality Degradation on Prediction Models Generated From Continuous Activity and Heart Rate Monitoring: Exploratory Analysis Using Simulation
por: Hearn, Jason, et al.
Publicado: (2023) -
End‐Diastolic Forward Flow and Restrictive Physiology in Repaired Tetralogy of Fallot: A Systematic Review and Meta‐Analysis
por: Van den Eynde, Jef, et al.
Publicado: (2022) -
Collaterals in congenital heart disease: when and how to treat?
por: Van De Bruaene, Alexander, et al.
Publicado: (2023) -
The discerning ear: cardiac auscultation in the era of artificial intelligence and telemedicine
por: Jani, Vivek, et al.
Publicado: (2021)